TipRanks
Molecular Partners (DE:6ML0)
FRANKFURT:6ML0
Germany Market
6ML0
Molecular Partners
RESEARCH TOOLSreports

Molecular Partners (6ML0) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

6ML0 Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Molecular
Partners
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6ML0 Stock 12 Month Forecast

Average Price Target

€8.92
▲(143.73% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Molecular Partners in the last 3 months. The average price target is €8.92 with a high forecast of €10.70 and a low forecast of €7.14. The average price target represents a 143.73% change from the last price of €3.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","11":"€11","4.25":"€4.25","6.5":"€6.5","8.75":"€8.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.70447964,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€10.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.9203997,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€8.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.13631976,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€7.14</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4.25,6.5,8.75,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.5,4.054190741538462,4.608381483076923,5.162572224615385,5.716762966153846,6.270953707692308,6.82514444923077,7.379335190769231,7.933525932307693,8.487716673846155,9.041907415384616,9.596098156923077,10.15028889846154,{"y":10.70447964,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.5,3.916953823076923,4.333907646153846,4.750861469230769,5.167815292307693,5.584769115384615,6.001722938461539,6.418676761538462,6.8356305846153855,7.252584407692308,7.6695382307692315,8.086492053846154,8.503445876923077,{"y":8.9203997,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.5,3.7797169046153845,4.059433809230769,4.339150713846154,4.618867618461539,4.898584523076924,5.178301427692308,5.4580183323076925,5.737735236923077,6.017452141538461,6.297169046153846,6.576885950769231,6.856602855384615,{"y":7.13631976,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.12,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.08,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.16,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.26,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.56,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.36,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.34,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.54,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€10.70Average Price Target€8.92Lowest Price Target€7.14
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Clear Street Analyst forecast on DE:6ML0
Mara Goldstein
Clear Street
Clear Street
€7.14
Buy
94.98%
Upside
Reiterated
09/04/26
Clear Street transfers coverage on Molecular Partners, keeps Buy ratingClear Street transfers coverage on Molecular Partners, keeps Buy rating
LifeSci Capital Analyst forecast on DE:6ML0
Charles Zhu
LifeSci Capital
LifeSci Capital
€10.7
Buy
192.47%
Upside
Reiterated
08/25/26
Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating
H.C. Wainwright Analyst forecast on DE:6ML0
Robert Burns
H.C. Wainwright
H.C. Wainwright
€11.6
Buy
216.84%
Upside
Reiterated
07/06/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (NASDAQ: ALNY), Molecular Partners (NASDAQ: MOLN) and Exelixis (NASDAQ: EXEL)
Leerink Partners Analyst forecast on DE:6ML0
Jonathan Chang
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Molecular Partners (NASDAQ: MOLN) and Park Dental Partners, Inc. (NASDAQ: PARK)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Clear Street Analyst forecast on DE:6ML0
Mara Goldstein
Clear Street
Clear Street
€7.14
Buy
94.98%
Upside
Reiterated
09/04/26
Clear Street transfers coverage on Molecular Partners, keeps Buy ratingClear Street transfers coverage on Molecular Partners, keeps Buy rating
LifeSci Capital Analyst forecast on DE:6ML0
Charles Zhu
LifeSci Capital
LifeSci Capital
€10.7
Buy
192.47%
Upside
Reiterated
08/25/26
Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating
H.C. Wainwright Analyst forecast on DE:6ML0
Robert Burns
H.C. Wainwright
H.C. Wainwright
€11.6
Buy
216.84%
Upside
Reiterated
07/06/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (NASDAQ: ALNY), Molecular Partners (NASDAQ: MOLN) and Exelixis (NASDAQ: EXEL)
Leerink Partners Analyst forecast on DE:6ML0
Jonathan Chang
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Molecular Partners (NASDAQ: MOLN) and Park Dental Partners, Inc. (NASDAQ: PARK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HROWHarrow Health
KURAKura Oncology
DNLIDenali Therapeutics
STOKStoke Therapeutics
CELCCelcuity
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molecular Partners

3 Months
Charles ZhuLifeSci Capital
Success Rate
7/13 ratings generated profit
54%
Average Return
-0.30%
Copying Charles Zhu's trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of -0.30% per trade.
1 Year
Jonathan ChangLeerink Partners
Success Rate
2/6 ratings generated profit
33%
Average Return
-10.83%
Copying Jonathan Chang's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -10.83% per trade.
2 Years
Charles ZhuLifeSci Capital
Success Rate
0/13 ratings generated profit
0%
Average Return
-12.16%
Copying Charles Zhu's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -12.16% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6ML0 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
3
6
5
6
2
Buy
1
1
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
7
6
6
2
In the current month, 6ML0 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6ML0 average Analyst price target in the past 3 months is 8.92.
Each month's total comprises the sum of three months' worth of ratings.

6ML0 Financial Forecast

6ML0 Earnings Forecast

The previous quarter’s earnings for 6ML0 were -€0.37.
The previous quarter’s earnings for 6ML0 were -€0.37.

6ML0 Sales Forecast

The previous quarter’s earnings for 6ML0 were €0.00.
The previous quarter’s earnings for 6ML0 were €0.00.

6ML0 Stock Forecast FAQ

What is DE:6ML0’s average 12-month price target, according to analysts?
Based on analyst ratings, Molecular Partners’s 12-month average price target is 8.92.
    What is DE:6ML0’s upside potential, based on the analysts’ average price target?
    Molecular Partners has 143.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Molecular Partners a Buy, Sell or Hold?
          Molecular Partners has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Molecular Partners’s share price target?
            The average share price target for Molecular Partners is 8.92. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €10.70 ,and the lowest forecast is €7.14. The average share price target represents 143.73% Increase from the current price of €3.66.
              What do analysts say about Molecular Partners?
              Molecular Partners’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Molecular Partners?
                To buy shares of DE:6ML0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.